# A Study of Accelerated Guideline-Directed Medical Therapy for Heart Failure

> **NCT07217106** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 342 (actual)

## Conditions studied

- Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07217106
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-03
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2025-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07217106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07217106, "A Study of Accelerated Guideline-Directed Medical Therapy for Heart Failure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07217106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*